CE & Events
- This event has passed.
Introduction to Postmarketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER
Tuesday, September 20th 2022
7:00 p.m. to 8:00 p.m.
This webinar will discuss the FDA’s postmarketing drug safety surveillance activities, how adverse event reports are collected and analyzed by FDA and how safety findings are communicated to the public.
1. Describe FDA’s postmarketing drug safety surveillance system
2. Identify the components of postmarketing reporting and signal detection
3. Summarize how adverse event reports are collected and analyzed by FDA
4. Describe how safety findings are communicated to the public
Activity Type: Knowledge
Contact Hours: 1.0
Heather Le, PharmD
VPhA Members: FREE
The Zoom link will be sent out to all registered attendees on the 20th
Registration is now closed.